Dismay as Sanofi announces UK plant closure
March 15, 2012Manufacturing and Production, Sales and Marketing Plavix, Sanofi, job losses, manufacturing
Sanofi has decided to close down a manufacturing facility in the North East of the UK with the loss of …
Cmed release Global Strategic and Regulatory Consulting Booklet
March 14, 2012Research and Development
The regulatory environments within the industry continue to change and vary internationally. Cmed’s regulatory and medical professionals keep track of …
Europe’s pharma sector : living through the crisis
March 14, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Greece, Tonarelli, Witty, austerity, pharma
Pharmaceutical markets across Europe have been badly hit by the economic crisis, with revenues in some countries being decimated by …
EMA begins pilot for electronic drug applications
March 14, 2012Medical Communications EMA, European Medicines Agency, eCTD
The European Medicines Agency has launched a pilot scheme that allows pharma firms to submit new drug applications electronically. The …
Maps and apps: video interviews with healthcare professionals
March 14, 2012Medical Communications Digital Blog, apps
Last month the Department of Health released ideas for new apps aimed at patients and doctors. Below are some video …
Charity attacks Scottish decision on Zytiga
March 14, 2012Sales and Marketing Janssen, NICE, PAS, Prostate Cancer Charity, Zytiga
Scotland’s medicines regulator has turned down Janssen’s prostate cancer pill Zytiga, leading to a backlash from charities. The Scottish Medicines …
Roche’s melanoma pill launched in UK
March 14, 2012Sales and Marketing BMS, CDF, NICE, Roche, Yervoy, Zelboraf
Roche’s Zelboraf has been launched in the UK to treat the deadliest form of skin cancer. Zelboraf (vemurafenib) is the …
AstraZeneca sues FDA over generic Seroquel
March 14, 2012Manufacturing and Production, Sales and Marketing AstraZeneca, FDA, Seroquel, US, generics
AstraZeneca has said it filed a lawsuit against the US FDA in a bid to block approval of generic versions …
Pfizer pulls out of $350 million insulin pact
March 14, 2012Research and Development, Sales and Marketing Biocon, Humalog, Lantus, NovoLog, Pfizer
Pfizer has walked away from a research deal with India’s biggest biotech firm Biocon. Both companies were working on a …
SHL talks about Autoinjector Development in Manufacturing Chemist’s latest issue
March 14, 2012Manufacturing and Production auto injector, autoinjector, manufacturing chemist, pen injector, shl group
Manufacturing Chemist, an established publication in the biopharmaceutical industry, recently approached SHL to share with their readers the company’s knowledge …
Merck warned over missing Januvia safety study
March 13, 2012Research and Development FDA, Januvia, Merck, study
Merck has been warned by the FDA that it must carry out a post-marketing safety study on diabetes treatments Januvia …
Science minister opens new Pfizer facility in Havant
March 13, 2012Manufacturing and Production Havant, Pfizer, R&D, Tucker, Willetts
Science minister David Willetts has opened Pfizer’s new state-of-the-art cold storage facility at its site in Havant. The new £7 …
Catalent continues investment in Global Clinical Supply services with German warehousing & controlled substance expansion
March 13, 2012Research and Development
Somerset, NJ – March 7, 2012 — Catalent Pharma Solutions announced the completion of extended warehousing facilities in Schorndorf, Germany …
Catalent Expert Presents on Protein Expression in CHO Cells: Comparison of GPEx® Technology to Traditional Cell Line Engineering at Cell Culture World Congress 2012
March 13, 2012Research and Development
Somerset, NJ February 21, 2012 — Michael Jenkins, Ph.D., General Manager of Catalent Pharma Solutions’ Middleton, WI facility, will present …
MHRA plans to cut red tape in the UK
March 13, 2012Manufacturing and Production EU, MHRA, pharma
The UK government’s drug safety regulator is calling on the pharma industry to help it eliminate unneccessary bureaucracy.The Medicines and …
Dr John Brown joins BioCity Nottingham’s board
March 13, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing BioCity Nottingham, BioCity Scotland, John Brown
Dr John Brown has been appointed as a non-executive director to the board of BioCity Nottingham Ltd, which runs one …
GSK expands apprenticeship programme
March 13, 2012Manufacturing and Production, Research and Development GSK, Hayes, R&D, manufacturing
GlaxoSmithKline has expanded its apprenticeship programme with the creation of positions spanning manufacturing, IT, and R&D. The multi-disciplinary scheme is …
NICE wants more information on Xarelto
March 13, 2012Sales and Marketing Bayer, DVT, NICE, Xarelto
NICE is asking Bayer for more information about its blood thinner Xarelto in new guidance. The watchdog is currently minded …
Sanofi’s new diabetes device: worth the price?
March 12, 2012Medical Communications NHS, Sanofi, app, diabetes, iBGStar, smartphone
Sanofi launched its new iPhone and iPod Touch blood sugar monitor to much fanfare this week, but its high price …
WHO joins regulators in manufacturing inspections alliance
March 12, 2012Manufacturing and Production API, EMA, FDA, WHO, manufacturing
The World Health Organization will join a shared inspection programme for active pharmaceutical ingredient (API) facilities piloted last year by …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
